Published trials used oral doses of 0.25 mg to 30 mg per day and intravenous single doses of 25 to 400 mcg/kg
NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure
Product is strictly for laboratory scientific research (RUO).
While much research focuses on bariatric surgery patients, the mechanisms of B12 deficiency during rapid weight loss overlap significantly with GLP-1 therapy
Stacking: B12, GLP-1s, and TRT Lipo-C + B12
Rodent (diet-induced obesity, 11 days) Subcutaneous 5-Amino-1MQ at roughly 34 mg/kg/day reduced body weight and white adipose mass without changing food intake or lean mass